[Differentiation between beta adrenergic and Ca 2+  antagonistic influencing components of beta receptor blockaders in the myocardium and in smooth muscles with special reference to Trasicor].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000498:Allyl Compounds; D000605:Amino Alcohols / Q000494:pharmacology*; D000818:Animals; D002118:Calcium / Q000037:antagonists & inhibitors*; D002415:Cats; D002642:Chick Embryo; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects*; D010210:Papillary Muscles / Q000187:drug effects; D010869:Pindolol / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011299:Prenylamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines; D011817:Rabbits; D051381:Rats; D013015:Sotalol / Q000494:pharmacology; D014599:Uterus; D014700:Verapamil / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D000498:Allyl Compounds; D000605:Amino Alcohols; D011437:Propylamines; D011433:Propranolol; D013015:Sotalol; D010869:Pindolol; D014700:Verapamil; D011299:Prenylamine; D011188:Potassium; D002118:Calcium
Differenzierung zwischen den beta-adrenolytischen und Ca 2+ -antagonistischen Wirkungskomponenten von beta-receptorenblockern am Myokard und an glatter Muskulatur unter besonderer Berücksichtigung von Trasicor.